Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Philippe A. Bilodeau
CD4 + T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis
Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary Epstein-Barr virus (EBV) has been nearly definitively linked to development of multiple sclerosis (MS); however, the exact roles of EBV itself and the immune response to it are only now being elucidated. Here, Bjornevik et al.
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
|
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Key Points Question Do observational data suggest interleukin-6 receptor blockers (IL-6RB) may be an effective and safe therapy for relapse prevention in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD)?
By Andreu Vilaseca, Philippe A. Bilodeau, Georgios Gakis, Andrea Savransky, Linda Nguyen, Sam I. Hooshmand, Sammita Satyanarayan, Carson E. Moseley, Chantal Roy-Hewitson, Mariano Marrodan, Haiwen Chen, Yoji Hoshina, Edgar Carnero Contentti, Lorna Galleguillos, Margaret Upchurch, Caitlin Jackson-Tarlton, Joanne Guo, Michelle Fabian, Akash Virupakshaiah, Georgina Arrambide, Emmanuelle Waubant, Laura Boschetti, Jorge Correale, Andres Villa, Brenda Banwell, Romain Marignier, Sean J. Pittock, Benjamin M. Greenberg, Jeffrey Bennett, Tracey A. Cho, Stacey L. Clardy, Andrew Solomon, Ilya Kister, Scott S. Zamvil, Jeffrey M. Gelfand, Pavle Repovic, Ahmed Z. Obeidat, Kyle Blackburn, Silvia N. Tenembaum, John Chen, Elias S. Sotirchos, Michael Levy, Eoin P. Flanagan, Fabián Hernández Murillo, Laura Cacciaguerra, Mulan Jiang, Dean M. Wingerchuk, Leah Haley, Adriana Casallas, Analisa Manin, Aniela Grzezulkowska, César Caparó-Zamalloa, Rafael Paterno, Stephanie B. Syc-Mazurzek, Susan E. Horsman
|
JAMA Network
Verified
The Impact of Anti-Amyloid Immunotherapies on Stroke Care
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
In the era of antiviral trials for MS, the answer lies in the details
After a seminal epidemiological study linked infection with the Epstein-Barr virus (EBV) to multiple sclerosis (MS), there is a consensus that EBV is the primary cause of MS (). Now, the question remains: How does EBV lead to MS, given that the majority of infected individuals do not develop the disease? Hypotheses addressing this question can be divided into two groups: (1) EBV acts as a trigger of self-perpetuating autoimmunity, or (2) EBV acts as a driver of MS pathology ().
More Than a Little Unsteady
About Interactive Medical Cases Each interactive case presents an evolving patient history and a series of questions and exercises designed to test your diagnostic and therapeutic skills. You will receive immediate feedback on your answers and treatment choices. Claim 1 AMA PRA Category 1 Credit™ (CME available to subscribers).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Philippe A.
Contact Philippe A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack